Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 380
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we make anesthesia for dogs safer with the help of nutrition?

    Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

    Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

    Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

    Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

    Backer Badge Funded